Related Experiment Video
Updated: Aug 6, 2026
09:51
Generation of Stable Human Cell Lines with Tetracycline-inducible (Tet-on) shRNA or cDNA Expression
Published on: March 5, 2013
MZ3 induces apoptosis in human leukemia cells
Liang Fang1, Qiaojun He, Yongzhou Hu
1Institute of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Zhejiang University, 353# Yan'an Rd., Hangzhou, Zhejiang, 310031, China.
Cancer Chemotherapy and Pharmacology
|August 11, 2006
Summary
The novel compound MZ3 demonstrates potent anti-leukemia activity by inducing apoptosis through the mitochondrial pathway. This combretastatin-A-4 analogue shows efficacy in both drug-resistant cell lines and in vivo models.
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- Combretastatin-A-4 analogues are investigated for anti-cancer properties.
- MZ3 is a synthesized analogue with reported activity against leukemia.
Purpose of the Study:
- To elucidate the cytotoxic mechanism of MZ3 in leukemia.
- To evaluate the in vitro and in vivo anti-leukemia potential of MZ3.
Main Methods:
- Cytotoxicity assessed via MTT assay.
- Apoptosis, mitochondrial membrane potential (DeltaPsim), and reactive oxygen species (ROS) measured by flow cytometry.
- DNA fragmentation analyzed by gel electrophoresis; protein expression by western blotting; in vivo efficacy in SCID mice.
Main Results:
- MZ3 showed high anti-cancer activity in six leukemia cell lines, including drug-resistant ones.
- MZ3 induced DNA fragmentation, increased ROS, and decreased DeltaPsim in HL60 cells.
- MZ3 activated caspase-3, modulated Bcl-2 family proteins and MAPKs, and prolonged survival in vivo.
Conclusions:
- MZ3 is a potent anti-leukemia agent effective both in vitro and in vivo.
- Mitochondrial apoptosis pathway, involving Bcl-2 family proteins and MAPKs, is implicated in MZ3's mechanism.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...